These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 27230546)

  • 1. Brain CYP2B induction can decrease nicotine levels in the brain.
    Garcia KLP; Lê AD; Tyndale RF
    Addict Biol; 2017 Sep; 22(5):1257-1266. PubMed ID: 27230546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Brain CYP2B Inhibition on Brain Nicotine Levels and Nicotine Self-Administration.
    Garcia KL; Coen K; Miksys S; Lê AD; Tyndale RF
    Neuropsychopharmacology; 2015 Jul; 40(8):1910-8. PubMed ID: 25652250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rat brain CYP2B induction by nicotine is persistent and does not involve nicotinic acetylcholine receptors.
    Khokhar JY; Miksys SL; Tyndale RF
    Brain Res; 2010 Aug; 1348():1-9. PubMed ID: 20599831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug metabolism within the brain changes drug response: selective manipulation of brain CYP2B alters propofol effects.
    Khokhar JY; Tyndale RF
    Neuropsychopharmacology; 2011 Feb; 36(3):692-700. PubMed ID: 21107310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional and cellular induction of nicotine-metabolizing CYP2B1 in rat brain by chronic nicotine treatment.
    Miksys S; Hoffmann E; Tyndale RF
    Biochem Pharmacol; 2000 Jun; 59(12):1501-11. PubMed ID: 10799646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subacute nicotine co-exposure has no effect on 2,2',3,5',6- pentachlorobiphenyl disposition but alters hepatic cytochrome P450 expression in the male rat.
    Stamou M; Uwimana E; Flannery BM; Kania-Korwel I; Lehmler HJ; Lein PJ
    Toxicology; 2015 Dec; 338():59-68. PubMed ID: 26463278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic nicotine treatment induces rat CYP2D in the brain but not in the liver: an investigation of induction and time course.
    Yue J; Miksys S; Hoffmann E; Tyndale RF
    J Psychiatry Neurosci; 2008 Jan; 33(1):54-63. PubMed ID: 18197273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotine kinetics in zebra finches in vivo and in vitro.
    Miksys S; Cappendijk SL; Perry WM; Zhao B; Tyndale RF
    Drug Metab Dispos; 2013 Jun; 41(6):1240-6. PubMed ID: 23530019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of nicotine metabolism on nicotine's pharmacological effects and behavioral responses: insights from a Cyp2a(4/5)bgs-null mouse.
    Li L; Jia K; Zhou X; McCallum SE; Hough LB; Ding X
    J Pharmacol Exp Ther; 2013 Dec; 347(3):746-54. PubMed ID: 24045421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracerebroventricularly and systemically delivered inhibitor of brain CYP2B (C8-Xanthate), even following chlorpyrifos exposure, reduces chlorpyrifos activation and toxicity in male rats.
    Khokhar JY; Tyndale RF
    Toxicol Sci; 2014 Jul; 140(1):49-60. PubMed ID: 24798379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotine Increases Codeine Analgesia Through the Induction of Brain CYP2D and Central Activation of Codeine to Morphine.
    McMillan DM; Tyndale RF
    Neuropsychopharmacology; 2015 Jun; 40(7):1804-12. PubMed ID: 25630571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction and recovery time course of rat brain CYP2E1 after nicotine treatment.
    Joshi M; Tyndale RF
    Drug Metab Dispos; 2006 Apr; 34(4):647-52. PubMed ID: 16434548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a novel neurotensin analog, NT69L, on nicotine-induced alterations in monoamine levels in rat brain.
    Liang Y; Boules M; Shaw AM; Williams K; Fredrickson P; Richelson E
    Brain Res; 2008 Sep; 1231():6-15. PubMed ID: 18687313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic neonatal nicotine upregulates heteromeric nicotinic acetylcholine receptor binding without change in subunit mRNA expression.
    Huang LZ; Winzer-Serhan UH
    Brain Res; 2006 Oct; 1113(1):94-109. PubMed ID: 16942759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rat hepatic CYP2E1 is induced by very low nicotine doses: an investigation of induction, time course, dose response, and mechanism.
    Micu AL; Miksys S; Sellers EM; Koop DR; Tyndale RF
    J Pharmacol Exp Ther; 2003 Sep; 306(3):941-7. PubMed ID: 12750430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain metabolic effects of acute nicotine.
    Pettegrew JW; Panchalingam K; McClure RJ; Levine J
    Neurochem Res; 2001 Feb; 26(2):181-5. PubMed ID: 11478746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inducing rat brain CYP2D with nicotine increases the rate of codeine tolerance; predicting the rate of tolerance from acute analgesic response.
    McMillan DM; Tyndale RF
    Biochem Pharmacol; 2017 Dec; 145():158-168. PubMed ID: 28837793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetaldehyde, a major constituent of tobacco smoke, enhances behavioral, endocrine, and neuronal responses to nicotine in adolescent and adult rats.
    Cao J; Belluzzi JD; Loughlin SE; Keyler DE; Pentel PR; Leslie FM
    Neuropsychopharmacology; 2007 Sep; 32(9):2025-35. PubMed ID: 17287824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low doses of nicotine and ethanol induce CYP2E1 and chlorzoxazone metabolism in rat liver.
    Howard LA; Micu AL; Sellers EM; Tyndale RF
    J Pharmacol Exp Ther; 2001 Nov; 299(2):542-50. PubMed ID: 11602665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective down-regulation of [(125)I]Y0-alpha-conotoxin MII binding in rat mesostriatal dopamine pathway following continuous infusion of nicotine.
    Mugnaini M; Garzotti M; Sartori I; Pilla M; Repeto P; Heidbreder CA; Tessari M
    Neuroscience; 2006; 137(2):565-72. PubMed ID: 16289885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.